Navidea Biopharmaceuticals, Inc.(NYSE Amex Equities : NAVB)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABBV | AbbVie, Inc. | -0.96% | 92.13 | 1.9% | $1192.97m | |
| JNJ | Johnson & Johnson | -0.87% | 144.44 | 0.7% | $1057.09m | |
| BMY | Bristol-Myers Squibb Co. | -0.57% | 60.79 | 1.0% | $967.46m | |
| PFE | Pfizer Inc. | 0.64% | 37.50 | 0.9% | $831.88m | |
| MRK | Merck & Co., Inc. | -0.22% | 76.38 | 0.7% | $796.50m | |
| LLY | Eli Lilly & Co. | -0.69% | 151.23 | 1.1% | $417.06m | |
| AZN | AstraZeneca Plc | -0.11% | 55.22 | 1.2% | $261.94m | |
| NVS | Novartis AG | -0.09% | 84.91 | 0.2% | $156.50m | |
| GSK | GlaxoSmithKline Plc | -0.37% | 40.88 | 0.2% | $140.53m | |
| NVO | Novo Nordisk A/S | 0.05% | 64.85 | 0.1% | $87.00m | |
| SNY | Sanofi | -0.30% | 47.30 | 0.2% | $78.78m | |
| RGEN | Repligen Corp. | -0.57% | 139.51 | 7.1% | $73.05m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 7.71% | 58.27 | 0.0% | $60.48m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 11.80% | 58.37 | 0.0% | $42.40m | |
| RETA | Reata Pharmaceuticals, Inc. | 1.04% | 160.00 | 3.4% | $38.83m |
Company Profile
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.